| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Checklist | 36 | 2021 | 830 | 5.590 |
Why?
|
| Surgical Procedures, Operative | 47 | 2020 | 1873 | 5.490 |
Why?
|
| Surgery Department, Hospital | 9 | 2020 | 175 | 2.690 |
Why?
|
| Operating Rooms | 18 | 2021 | 813 | 2.600 |
Why?
|
| World Health Organization | 20 | 2019 | 1317 | 2.580 |
Why?
|
| Medical Errors | 24 | 2014 | 1296 | 2.290 |
Why?
|
| Safety Management | 12 | 2018 | 782 | 1.840 |
Why?
|
| Oximetry | 8 | 2021 | 467 | 1.790 |
Why?
|
| General Surgery | 14 | 2022 | 1633 | 1.630 |
Why?
|
| Postoperative Complications | 32 | 2022 | 15244 | 1.620 |
Why?
|
| Hospital Mortality | 17 | 2019 | 5310 | 1.530 |
Why?
|
| Surgical Sponges | 5 | 2009 | 46 | 1.510 |
Why?
|
| Intraoperative Complications | 10 | 2016 | 1188 | 1.490 |
Why?
|
| Maternal Health Services | 6 | 2017 | 452 | 1.480 |
Why?
|
| Foreign Bodies | 6 | 2009 | 398 | 1.340 |
Why?
|
| Patient Care Team | 14 | 2021 | 2527 | 1.240 |
Why?
|
| Quality Assurance, Health Care | 15 | 2017 | 2211 | 1.150 |
Why?
|
| Hospitals | 12 | 2020 | 3937 | 1.090 |
Why?
|
| Surgical Instruments | 5 | 2019 | 394 | 1.090 |
Why?
|
| Delivery, Obstetric | 10 | 2020 | 904 | 1.020 |
Why?
|
| Neurosurgical Procedures | 5 | 2012 | 2002 | 0.990 |
Why?
|
| Health Care Costs | 10 | 2016 | 3203 | 0.970 |
Why?
|
| Perinatal Mortality | 4 | 2020 | 105 | 0.930 |
Why?
|
| Thyroid Nodule | 11 | 2019 | 750 | 0.910 |
Why?
|
| Developing Countries | 14 | 2017 | 2789 | 0.910 |
Why?
|
| Financial Management, Hospital | 2 | 2013 | 74 | 0.890 |
Why?
|
| Physician's Role | 5 | 2017 | 942 | 0.830 |
Why?
|
| Guideline Adherence | 14 | 2019 | 2266 | 0.820 |
Why?
|
| Monitoring, Intraoperative | 4 | 2014 | 953 | 0.820 |
Why?
|
| Hospital Administration | 3 | 2015 | 353 | 0.820 |
Why?
|
| Diagnosis-Related Groups | 2 | 2013 | 454 | 0.800 |
Why?
|
| Cost Sharing | 3 | 2013 | 407 | 0.760 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 253 | 0.750 |
Why?
|
| Malpractice | 10 | 2019 | 569 | 0.740 |
Why?
|
| Health Care Reform | 7 | 2017 | 1261 | 0.740 |
Why?
|
| Health Status Indicators | 4 | 2011 | 968 | 0.730 |
Why?
|
| India | 16 | 2020 | 2187 | 0.730 |
Why?
|
| Delivery of Health Care | 12 | 2017 | 5304 | 0.730 |
Why?
|
| Postoperative Care | 4 | 2017 | 1484 | 0.710 |
Why?
|
| Hospitals, Public | 3 | 2016 | 207 | 0.710 |
Why?
|
| Maternal Mortality | 9 | 2020 | 310 | 0.710 |
Why?
|
| Mass Vaccination | 1 | 2021 | 105 | 0.700 |
Why?
|
| Colectomy | 5 | 2017 | 681 | 0.680 |
Why?
|
| Clinical Protocols | 4 | 2020 | 1459 | 0.670 |
Why?
|
| Hospital Costs | 3 | 2017 | 980 | 0.670 |
Why?
|
| Medical Informatics Applications | 4 | 2003 | 186 | 0.660 |
Why?
|
| Specialties, Surgical | 6 | 2016 | 389 | 0.650 |
Why?
|
| Child Health Services | 3 | 2013 | 667 | 0.650 |
Why?
|
| Infection Control | 4 | 2020 | 962 | 0.640 |
Why?
|
| Health Services Accessibility | 8 | 2019 | 5133 | 0.640 |
Why?
|
| Thyroid Neoplasms | 13 | 2020 | 2274 | 0.640 |
Why?
|
| Clinical Competence | 13 | 2022 | 4681 | 0.630 |
Why?
|
| Humans | 217 | 2022 | 742088 | 0.620 |
Why?
|
| History, 21st Century | 9 | 2021 | 1533 | 0.610 |
Why?
|
| Capital Punishment | 2 | 2008 | 31 | 0.590 |
Why?
|
| Health Resources | 3 | 2013 | 911 | 0.590 |
Why?
|
| Parturition | 6 | 2019 | 436 | 0.590 |
Why?
|
| Medically Uninsured | 3 | 2017 | 852 | 0.580 |
Why?
|
| Regression Analysis | 4 | 2014 | 6452 | 0.580 |
Why?
|
| Medical Staff, Hospital | 3 | 2020 | 603 | 0.580 |
Why?
|
| Quality Improvement | 19 | 2019 | 3738 | 0.570 |
Why?
|
| Physician-Patient Relations | 13 | 2019 | 3215 | 0.560 |
Why?
|
| United States | 61 | 2021 | 69693 | 0.550 |
Why?
|
| Quality of Health Care | 10 | 2019 | 4369 | 0.550 |
Why?
|
| Electronic Prescribing | 1 | 2017 | 121 | 0.540 |
Why?
|
| Anesthesiology | 3 | 2015 | 1043 | 0.520 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2016 | 189 | 0.520 |
Why?
|
| Binomial Distribution | 1 | 2014 | 25 | 0.510 |
Why?
|
| Intraoperative Care | 5 | 2013 | 766 | 0.510 |
Why?
|
| Inservice Training | 3 | 2016 | 392 | 0.500 |
Why?
|
| Antisepsis | 2 | 2012 | 18 | 0.490 |
Why?
|
| Perioperative Care | 6 | 2019 | 997 | 0.490 |
Why?
|
| Thyroidectomy | 10 | 2022 | 877 | 0.480 |
Why?
|
| Neuroendoscopy | 1 | 2015 | 105 | 0.480 |
Why?
|
| Wounds and Injuries | 4 | 2014 | 2400 | 0.480 |
Why?
|
| Anesthesia | 6 | 2016 | 1548 | 0.480 |
Why?
|
| Advance Care Planning | 6 | 2019 | 660 | 0.470 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3130 | 0.470 |
Why?
|
| Health Care Sector | 2 | 2009 | 194 | 0.470 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3236 | 0.470 |
Why?
|
| Triage | 1 | 2020 | 977 | 0.450 |
Why?
|
| Biomedical Technology | 3 | 2000 | 221 | 0.450 |
Why?
|
| History, 20th Century | 8 | 2021 | 2739 | 0.440 |
Why?
|
| Apgar Score | 2 | 2010 | 123 | 0.440 |
Why?
|
| Communication | 10 | 2022 | 3728 | 0.440 |
Why?
|
| Skull Base | 1 | 2015 | 299 | 0.430 |
Why?
|
| Healthcare Disparities | 4 | 2014 | 3151 | 0.420 |
Why?
|
| Gift Giving | 1 | 2012 | 80 | 0.420 |
Why?
|
| Parathyroidectomy | 3 | 2013 | 235 | 0.420 |
Why?
|
| Terminal Care | 5 | 2019 | 1688 | 0.410 |
Why?
|
| Patient Discharge | 4 | 2018 | 3300 | 0.400 |
Why?
|
| Infant Mortality | 5 | 2017 | 754 | 0.400 |
Why?
|
| Likelihood Functions | 1 | 2014 | 1003 | 0.390 |
Why?
|
| Female | 107 | 2022 | 379592 | 0.390 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 2861 | 0.380 |
Why?
|
| Palliative Care | 5 | 2019 | 3478 | 0.370 |
Why?
|
| Health Policy | 5 | 2016 | 2657 | 0.370 |
Why?
|
| Hospital Bed Capacity | 2 | 2013 | 213 | 0.370 |
Why?
|
| Intracranial Hemorrhages | 5 | 2012 | 854 | 0.360 |
Why?
|
| Legislation as Topic | 1 | 2009 | 80 | 0.350 |
Why?
|
| Thyroid Gland | 5 | 2019 | 1172 | 0.350 |
Why?
|
| Parathyroid Hormone | 5 | 2022 | 1801 | 0.350 |
Why?
|
| Insurance, Health | 5 | 2017 | 2493 | 0.350 |
Why?
|
| South Carolina | 6 | 2018 | 99 | 0.340 |
Why?
|
| National Health Insurance, United States | 1 | 2009 | 104 | 0.340 |
Why?
|
| Organizational Innovation | 3 | 2017 | 559 | 0.340 |
Why?
|
| Interprofessional Relations | 2 | 2019 | 1008 | 0.340 |
Why?
|
| Leadership | 4 | 2016 | 1357 | 0.340 |
Why?
|
| Torture | 1 | 2009 | 53 | 0.340 |
Why?
|
| Health Care Surveys | 9 | 2019 | 2451 | 0.330 |
Why?
|
| Government | 1 | 2009 | 165 | 0.330 |
Why?
|
| Health Services | 1 | 2014 | 758 | 0.330 |
Why?
|
| Risk | 7 | 2019 | 9679 | 0.330 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.320 |
Why?
|
| Male | 88 | 2022 | 349538 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 3 | 2012 | 1473 | 0.320 |
Why?
|
| Risk Management | 3 | 2019 | 571 | 0.310 |
Why?
|
| Carcinoma | 5 | 2018 | 2374 | 0.310 |
Why?
|
| Parathyroid Neoplasms | 3 | 2018 | 245 | 0.310 |
Why?
|
| Models, Statistical | 2 | 2014 | 5100 | 0.310 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.300 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2018 | 324 | 0.300 |
Why?
|
| Academic Medical Centers | 4 | 2011 | 2749 | 0.300 |
Why?
|
| Length of Stay | 4 | 2017 | 6294 | 0.300 |
Why?
|
| Surgical Wound Infection | 3 | 2012 | 1538 | 0.300 |
Why?
|
| Prisons | 1 | 2009 | 160 | 0.290 |
Why?
|
| Quality Indicators, Health Care | 5 | 2017 | 1831 | 0.290 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 1638 | 0.290 |
Why?
|
| Professional Practice | 2 | 2006 | 326 | 0.290 |
Why?
|
| Health Plan Implementation | 3 | 2019 | 351 | 0.290 |
Why?
|
| Internship and Residency | 6 | 2018 | 5774 | 0.290 |
Why?
|
| Infant, Newborn | 16 | 2020 | 25575 | 0.290 |
Why?
|
| Aged | 50 | 2020 | 162944 | 0.280 |
Why?
|
| Emergency Medical Services | 4 | 2014 | 1914 | 0.280 |
Why?
|
| Cross Infection | 2 | 2020 | 1413 | 0.280 |
Why?
|
| Middle Aged | 59 | 2020 | 213127 | 0.280 |
Why?
|
| Social Isolation | 1 | 2009 | 363 | 0.270 |
Why?
|
| Advance Directives | 3 | 2018 | 245 | 0.270 |
Why?
|
| Prisoners | 1 | 2009 | 296 | 0.270 |
Why?
|
| Ethics, Professional | 1 | 2006 | 102 | 0.270 |
Why?
|
| Mathematical Computing | 1 | 2005 | 147 | 0.270 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 1499 | 0.260 |
Why?
|
| Program Evaluation | 5 | 2018 | 2485 | 0.260 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 500 | 0.260 |
Why?
|
| Attitude of Health Personnel | 9 | 2021 | 3839 | 0.260 |
Why?
|
| Patient Care | 1 | 2011 | 639 | 0.260 |
Why?
|
| Midwifery | 2 | 2017 | 131 | 0.260 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 950 | 0.260 |
Why?
|
| Rectum | 1 | 2010 | 903 | 0.250 |
Why?
|
| Cost Savings | 1 | 2010 | 925 | 0.250 |
Why?
|
| Economic Development | 2 | 2015 | 69 | 0.250 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2018 | 740 | 0.250 |
Why?
|
| Biopsy, Fine-Needle | 9 | 2019 | 1093 | 0.250 |
Why?
|
| Peer Group | 2 | 2022 | 635 | 0.250 |
Why?
|
| Pregnancy | 17 | 2020 | 29087 | 0.250 |
Why?
|
| Insurance Coverage | 5 | 2017 | 1895 | 0.250 |
Why?
|
| Hyperparathyroidism | 1 | 2006 | 339 | 0.250 |
Why?
|
| Anesthetics, Intravenous | 1 | 2008 | 417 | 0.240 |
Why?
|
| Health Services for the Aged | 1 | 2007 | 269 | 0.240 |
Why?
|
| Critical Illness | 5 | 2019 | 2665 | 0.240 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2004 | 35 | 0.240 |
Why?
|
| Cytodiagnosis | 4 | 2018 | 435 | 0.240 |
Why?
|
| Inpatients | 3 | 2016 | 2495 | 0.240 |
Why?
|
| Health Expenditures | 5 | 2016 | 2346 | 0.240 |
Why?
|
| Medicare | 13 | 2017 | 6532 | 0.230 |
Why?
|
| Four-Dimensional Computed Tomography | 2 | 2018 | 145 | 0.230 |
Why?
|
| Carcinoma, Papillary | 5 | 2016 | 781 | 0.230 |
Why?
|
| Adrenalectomy | 2 | 2018 | 342 | 0.230 |
Why?
|
| Blood Loss, Surgical | 5 | 2018 | 656 | 0.230 |
Why?
|
| Computer Graphics | 1 | 2005 | 360 | 0.230 |
Why?
|
| Life Expectancy | 4 | 2015 | 1183 | 0.230 |
Why?
|
| Cause of Death | 2 | 2011 | 3571 | 0.230 |
Why?
|
| Retrospective Studies | 34 | 2022 | 77098 | 0.220 |
Why?
|
| Critical Care | 3 | 2016 | 2640 | 0.220 |
Why?
|
| Japan | 3 | 2021 | 1360 | 0.220 |
Why?
|
| Clostridium Infections | 1 | 2009 | 548 | 0.220 |
Why?
|
| Physical Examination | 2 | 2006 | 1239 | 0.220 |
Why?
|
| Military Medicine | 1 | 2004 | 176 | 0.220 |
Why?
|
| Patient Participation | 3 | 2014 | 1445 | 0.220 |
Why?
|
| Ethics, Medical | 1 | 2008 | 791 | 0.210 |
Why?
|
| Emergency Service, Hospital | 4 | 2016 | 7645 | 0.210 |
Why?
|
| Geriatrics | 1 | 2007 | 396 | 0.210 |
Why?
|
| Asia | 3 | 2015 | 607 | 0.210 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 2062 | 0.210 |
Why?
|
| Africa South of the Sahara | 3 | 2020 | 724 | 0.210 |
Why?
|
| Confidence Intervals | 4 | 2014 | 2970 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 7276 | 0.210 |
Why?
|
| Adult | 47 | 2019 | 213712 | 0.200 |
Why?
|
| Ambulatory Care | 3 | 2016 | 2706 | 0.200 |
Why?
|
| Colon | 1 | 2010 | 1773 | 0.200 |
Why?
|
| Social Class | 1 | 2011 | 1995 | 0.200 |
Why?
|
| Poisson Distribution | 3 | 2014 | 512 | 0.200 |
Why?
|
| Pandemics | 5 | 2021 | 8328 | 0.200 |
Why?
|
| Cost Control | 2 | 2013 | 624 | 0.190 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 3611 | 0.190 |
Why?
|
| Hypocalcemia | 1 | 2022 | 191 | 0.190 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2018 | 600 | 0.190 |
Why?
|
| Insurance Claim Review | 3 | 2014 | 720 | 0.190 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3667 | 0.190 |
Why?
|
| Aged, 80 and over | 23 | 2019 | 57683 | 0.190 |
Why?
|
| Literature | 1 | 2000 | 16 | 0.190 |
Why?
|
| Decision Making | 5 | 2020 | 3869 | 0.190 |
Why?
|
| Cesarean Section | 4 | 2017 | 1363 | 0.190 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2020 | 43 | 0.190 |
Why?
|
| Education, Medical, Continuing | 2 | 2019 | 839 | 0.190 |
Why?
|
| Health Services Research | 4 | 2017 | 1834 | 0.180 |
Why?
|
| Consumer Advocacy | 1 | 2000 | 81 | 0.180 |
Why?
|
| Risk Adjustment | 4 | 2017 | 594 | 0.180 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2020 | 68 | 0.180 |
Why?
|
| Decision Support Techniques | 2 | 2013 | 1952 | 0.180 |
Why?
|
| Convalescence | 1 | 2020 | 105 | 0.180 |
Why?
|
| Video Recording | 2 | 2017 | 944 | 0.170 |
Why?
|
| Sensitivity and Specificity | 8 | 2018 | 14720 | 0.170 |
Why?
|
| Education, Nursing, Continuing | 1 | 2019 | 75 | 0.170 |
Why?
|
| Technetium Tc 99m Sestamibi | 5 | 2018 | 176 | 0.170 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 1973 | 0.170 |
Why?
|
| Managed Care Programs | 2 | 2009 | 949 | 0.170 |
Why?
|
| Chi-Square Distribution | 5 | 2017 | 3510 | 0.170 |
Why?
|
| Hyperparathyroidism, Primary | 2 | 2013 | 155 | 0.170 |
Why?
|
| Liability, Legal | 3 | 2010 | 213 | 0.160 |
Why?
|
| Expert Systems | 1 | 1998 | 81 | 0.160 |
Why?
|
| Ultrasonography | 12 | 2019 | 5978 | 0.160 |
Why?
|
| Preoperative Care | 4 | 2016 | 2245 | 0.160 |
Why?
|
| Plasminogen | 1 | 1998 | 152 | 0.160 |
Why?
|
| Rural Health Services | 2 | 2019 | 379 | 0.160 |
Why?
|
| Health Facility Administration | 1 | 2018 | 31 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 7770 | 0.160 |
Why?
|
| Linear Models | 6 | 2019 | 5948 | 0.160 |
Why?
|
| Databases, Factual | 7 | 2017 | 7716 | 0.160 |
Why?
|
| Risk Factors | 17 | 2018 | 72145 | 0.160 |
Why?
|
| Primary Health Care | 4 | 2019 | 4551 | 0.160 |
Why?
|
| Pediatrics | 1 | 2013 | 3462 | 0.160 |
Why?
|
| Writing | 1 | 2000 | 205 | 0.160 |
Why?
|
| Appendicitis | 2 | 2016 | 644 | 0.160 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1998 | 150 | 0.160 |
Why?
|
| Patient Preference | 2 | 2016 | 886 | 0.150 |
Why?
|
| Hospitalization | 8 | 2017 | 10232 | 0.150 |
Why?
|
| Health Facility Merger | 1 | 2018 | 53 | 0.150 |
Why?
|
| Pilot Projects | 7 | 2019 | 8297 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2008 | 2616 | 0.150 |
Why?
|
| Aneurysm, Ruptured | 2 | 2012 | 452 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2012 | 638 | 0.150 |
Why?
|
| Treatment Outcome | 12 | 2018 | 62966 | 0.150 |
Why?
|
| Internationality | 3 | 2016 | 1002 | 0.150 |
Why?
|
| Physical Exertion | 1 | 2020 | 695 | 0.150 |
Why?
|
| Injury Severity Score | 3 | 2009 | 1013 | 0.140 |
Why?
|
| North America | 1 | 2020 | 1249 | 0.140 |
Why?
|
| Time Factors | 14 | 2020 | 40054 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1178 | 0.140 |
Why?
|
| Emergency Treatment | 2 | 2016 | 517 | 0.140 |
Why?
|
| Research Design | 3 | 2017 | 5979 | 0.140 |
Why?
|
| Safety | 3 | 2008 | 1185 | 0.140 |
Why?
|
| Hospital Units | 1 | 2017 | 141 | 0.140 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2016 | 60 | 0.140 |
Why?
|
| Hospitals, University | 2 | 2009 | 571 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 6 | 2017 | 5385 | 0.140 |
Why?
|
| Surgicenters | 1 | 2016 | 46 | 0.140 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 281 | 0.140 |
Why?
|
| Predictive Value of Tests | 7 | 2012 | 15056 | 0.140 |
Why?
|
| Thromboembolism | 2 | 2012 | 983 | 0.140 |
Why?
|
| History, 19th Century | 2 | 2012 | 720 | 0.140 |
Why?
|
| Health Communication | 1 | 2019 | 213 | 0.140 |
Why?
|
| Medical Audit | 2 | 2014 | 467 | 0.140 |
Why?
|
| Evaluation Studies as Topic | 2 | 2008 | 1676 | 0.140 |
Why?
|
| Hernia | 1 | 2016 | 71 | 0.130 |
Why?
|
| Public Policy | 2 | 2011 | 572 | 0.130 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 1402 | 0.130 |
Why?
|
| Logistic Models | 7 | 2013 | 13403 | 0.130 |
Why?
|
| Quality of Life | 2 | 2019 | 12730 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1998 | 520 | 0.130 |
Why?
|
| Intensive Care Units | 2 | 2011 | 3679 | 0.130 |
Why?
|
| Equipment Safety | 1 | 2016 | 264 | 0.130 |
Why?
|
| Personnel, Hospital | 1 | 2017 | 283 | 0.130 |
Why?
|
| Interviews as Topic | 2 | 2013 | 2536 | 0.130 |
Why?
|
| Population Density | 1 | 2015 | 194 | 0.130 |
Why?
|
| Infant | 10 | 2019 | 35070 | 0.130 |
Why?
|
| Oxytocics | 1 | 2015 | 68 | 0.130 |
Why?
|
| Risk Assessment | 11 | 2019 | 23320 | 0.130 |
Why?
|
| Prospective Studies | 15 | 2020 | 53187 | 0.130 |
Why?
|
| Postpartum Period | 2 | 2018 | 1078 | 0.130 |
Why?
|
| Fetal Death | 1 | 2016 | 447 | 0.120 |
Why?
|
| Medical Futility | 1 | 2016 | 126 | 0.120 |
Why?
|
| Africa | 2 | 2015 | 670 | 0.120 |
Why?
|
| Emergencies | 2 | 2011 | 1164 | 0.120 |
Why?
|
| Sphenoid Bone | 1 | 2015 | 172 | 0.120 |
Why?
|
| Mental Competency | 1 | 2016 | 176 | 0.120 |
Why?
|
| Health Priorities | 1 | 2017 | 379 | 0.120 |
Why?
|
| Body Temperature | 2 | 2008 | 776 | 0.120 |
Why?
|
| Epidemics | 1 | 2020 | 521 | 0.120 |
Why?
|
| Heart Rate | 4 | 2010 | 4091 | 0.120 |
Why?
|
| Multivariate Analysis | 6 | 2013 | 12242 | 0.120 |
Why?
|
| Blood Transfusion | 3 | 2014 | 1296 | 0.120 |
Why?
|
| Adenoma | 2 | 2018 | 2168 | 0.120 |
Why?
|
| Appendectomy | 2 | 2016 | 400 | 0.120 |
Why?
|
| Labor, Obstetric | 1 | 2017 | 333 | 0.120 |
Why?
|
| Disclosure | 2 | 2012 | 736 | 0.120 |
Why?
|
| Internet | 3 | 2000 | 3062 | 0.120 |
Why?
|
| El Salvador | 1 | 2013 | 39 | 0.120 |
Why?
|
| Adolescent | 20 | 2019 | 85649 | 0.120 |
Why?
|
| Radionuclide Imaging | 4 | 2018 | 2027 | 0.120 |
Why?
|
| Health Status | 2 | 2017 | 4030 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2003 | 1162 | 0.110 |
Why?
|
| Vital Statistics | 1 | 2013 | 34 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2022 | 1004 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 359 | 0.110 |
Why?
|
| Hospitals, Voluntary | 1 | 2013 | 40 | 0.110 |
Why?
|
| Physicians | 5 | 2020 | 4554 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2015 | 263 | 0.110 |
Why?
|
| Thalamic Diseases | 1 | 2012 | 16 | 0.110 |
Why?
|
| Capacity Building | 1 | 2015 | 248 | 0.110 |
Why?
|
| Hospitals, Community | 2 | 2015 | 348 | 0.110 |
Why?
|
| Bronchogenic Cyst | 1 | 2012 | 29 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2021 | 2899 | 0.110 |
Why?
|
| Incidence | 7 | 2015 | 20928 | 0.110 |
Why?
|
| Stillbirth | 1 | 2015 | 346 | 0.110 |
Why?
|
| Surgical Equipment | 1 | 2012 | 57 | 0.110 |
Why?
|
| Minnesota | 2 | 2005 | 343 | 0.110 |
Why?
|
| Zambia | 1 | 2013 | 261 | 0.110 |
Why?
|
| Foundations | 1 | 2012 | 94 | 0.110 |
Why?
|
| Social Behavior | 1 | 2019 | 1128 | 0.110 |
Why?
|
| Manikins | 1 | 2014 | 238 | 0.110 |
Why?
|
| Economics, Medical | 2 | 2016 | 113 | 0.110 |
Why?
|
| Hydrocephalus | 2 | 2012 | 746 | 0.110 |
Why?
|
| Operating Room Nursing | 2 | 2019 | 26 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 2014 | 156 | 0.100 |
Why?
|
| Policy Making | 2 | 2011 | 554 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1683 | 0.100 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 3391 | 0.100 |
Why?
|
| Nose | 1 | 2015 | 509 | 0.100 |
Why?
|
| Analysis of Variance | 4 | 2019 | 6365 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2018 | 3740 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2015 | 258 | 0.100 |
Why?
|
| Feedback | 1 | 2015 | 793 | 0.100 |
Why?
|
| Neoplasms | 5 | 2020 | 21596 | 0.100 |
Why?
|
| Patient-Centered Care | 2 | 2019 | 1436 | 0.100 |
Why?
|
| Boston | 4 | 2017 | 9305 | 0.100 |
Why?
|
| Patient Simulation | 1 | 2014 | 308 | 0.100 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 454 | 0.100 |
Why?
|
| Program Development | 2 | 2019 | 1314 | 0.100 |
Why?
|
| Dissent and Disputes | 1 | 2012 | 138 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 8829 | 0.100 |
Why?
|
| Malignant Hyperthermia | 1 | 2011 | 73 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2020 | 2680 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2018 | 1548 | 0.100 |
Why?
|
| Sample Size | 1 | 2014 | 844 | 0.100 |
Why?
|
| Oxytocin | 1 | 2015 | 395 | 0.100 |
Why?
|
| Persuasive Communication | 1 | 2011 | 59 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2372 | 0.100 |
Why?
|
| Medical Staff | 1 | 2011 | 43 | 0.100 |
Why?
|
| Embolism, Air | 1 | 2011 | 111 | 0.100 |
Why?
|
| Australia | 2 | 2012 | 1167 | 0.090 |
Why?
|
| Dura Mater | 1 | 2012 | 291 | 0.090 |
Why?
|
| Oxyphil Cells | 1 | 2011 | 57 | 0.090 |
Why?
|
| Defensive Medicine | 1 | 2010 | 48 | 0.090 |
Why?
|
| Africa, Northern | 1 | 2010 | 82 | 0.090 |
Why?
|
| Books | 1 | 2010 | 23 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 2012 | 220 | 0.090 |
Why?
|
| Aviation | 1 | 2010 | 42 | 0.090 |
Why?
|
| Minority Groups | 1 | 2018 | 1215 | 0.090 |
Why?
|
| Washington | 1 | 2011 | 313 | 0.090 |
Why?
|
| Calcitonin | 1 | 2011 | 336 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2011 | 126 | 0.090 |
Why?
|
| Malaria, Vivax | 1 | 2012 | 172 | 0.090 |
Why?
|
| Policy | 1 | 2014 | 504 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2012 | 579 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2014 | 481 | 0.090 |
Why?
|
| Housekeeping, Hospital | 1 | 2009 | 17 | 0.090 |
Why?
|
| Private Sector | 1 | 2013 | 390 | 0.090 |
Why?
|
| Odds Ratio | 4 | 2011 | 9846 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 337 | 0.090 |
Why?
|
| Seizures | 2 | 2012 | 2851 | 0.090 |
Why?
|
| Hashimoto Disease | 1 | 2011 | 93 | 0.090 |
Why?
|
| Middle East | 1 | 2010 | 219 | 0.090 |
Why?
|
| Young Adult | 12 | 2019 | 56350 | 0.090 |
Why?
|
| Population Groups | 1 | 2011 | 208 | 0.090 |
Why?
|
| Collagen | 1 | 1998 | 2684 | 0.090 |
Why?
|
| Health Services Needs and Demand | 3 | 2015 | 1411 | 0.090 |
Why?
|
| New Zealand | 1 | 2010 | 357 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2968 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2283 | 0.090 |
Why?
|
| Uganda | 1 | 2014 | 1239 | 0.090 |
Why?
|
| Patients | 1 | 2016 | 892 | 0.090 |
Why?
|
| Students, Medical | 1 | 2022 | 1858 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 15530 | 0.090 |
Why?
|
| Contrast Media | 3 | 2012 | 5295 | 0.090 |
Why?
|
| Compensation and Redress | 2 | 2007 | 71 | 0.090 |
Why?
|
| Patient Readmission | 2 | 2013 | 3111 | 0.080 |
Why?
|
| Patient Selection | 2 | 2018 | 4214 | 0.080 |
Why?
|
| Latin America | 1 | 2010 | 381 | 0.080 |
Why?
|
| Health Facilities | 3 | 2019 | 573 | 0.080 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 39004 | 0.080 |
Why?
|
| Mandatory Reporting | 1 | 2010 | 121 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 9185 | 0.080 |
Why?
|
| Pain | 2 | 2016 | 4961 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2019 | 40955 | 0.080 |
Why?
|
| Hospice Care | 1 | 2016 | 671 | 0.080 |
Why?
|
| Poverty Areas | 1 | 2010 | 273 | 0.080 |
Why?
|
| Hyperthyroidism | 1 | 2010 | 293 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1806 | 0.080 |
Why?
|
| Pancuronium | 1 | 2008 | 45 | 0.080 |
Why?
|
| Prenatal Care | 1 | 2015 | 1088 | 0.080 |
Why?
|
| Punishment | 1 | 2009 | 98 | 0.080 |
Why?
|
| Thiopental | 1 | 2008 | 59 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1239 | 0.080 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2008 | 45 | 0.080 |
Why?
|
| Politics | 1 | 1995 | 790 | 0.080 |
Why?
|
| Aging | 1 | 2007 | 8626 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 253 | 0.080 |
Why?
|
| Brain Edema | 1 | 2012 | 617 | 0.080 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2017 | 1208 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 3014 | 0.080 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 540 | 0.080 |
Why?
|
| Potassium Chloride | 1 | 2008 | 238 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2281 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 865 | 0.080 |
Why?
|
| Housing for the Elderly | 1 | 2007 | 17 | 0.080 |
Why?
|
| Cerebral Infarction | 1 | 2012 | 1007 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 2575 | 0.080 |
Why?
|
| Child | 10 | 2019 | 77478 | 0.080 |
Why?
|
| Developed Countries | 1 | 2010 | 436 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2009 | 414 | 0.070 |
Why?
|
| Esophagectomy | 1 | 2011 | 447 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 9941 | 0.070 |
Why?
|
| Vision Tests | 1 | 1988 | 167 | 0.070 |
Why?
|
| Informed Consent | 1 | 2013 | 991 | 0.070 |
Why?
|
| Benchmarking | 3 | 2017 | 1038 | 0.070 |
Why?
|
| Reoperation | 4 | 2018 | 4200 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2795 | 0.070 |
Why?
|
| Monitoring, Physiologic | 2 | 2006 | 1737 | 0.070 |
Why?
|
| Supreme Court Decisions | 1 | 2008 | 128 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 2028 | 0.070 |
Why?
|
| Hallucinations | 1 | 2009 | 360 | 0.070 |
Why?
|
| Iatrogenic Disease | 2 | 2007 | 545 | 0.070 |
Why?
|
| Ethics, Nursing | 1 | 2006 | 25 | 0.070 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 404 | 0.070 |
Why?
|
| Costa Rica | 2 | 2017 | 177 | 0.070 |
Why?
|
| Feasibility Studies | 4 | 2019 | 5062 | 0.070 |
Why?
|
| England | 2 | 2019 | 523 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2009 | 550 | 0.070 |
Why?
|
| Massachusetts | 3 | 2019 | 8662 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2011 | 2295 | 0.070 |
Why?
|
| Neurosurgery | 1 | 2012 | 642 | 0.070 |
Why?
|
| Codes of Ethics | 1 | 2006 | 62 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2009 | 10248 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2713 | 0.070 |
Why?
|
| Data Collection | 3 | 2016 | 3339 | 0.070 |
Why?
|
| Jurisprudence | 1 | 2006 | 109 | 0.070 |
Why?
|
| Obstetrics | 1 | 2013 | 657 | 0.070 |
Why?
|
| Insurance, Liability | 1 | 2006 | 102 | 0.070 |
Why?
|
| Unnecessary Procedures | 1 | 2009 | 431 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 2010 | 704 | 0.070 |
Why?
|
| Demography | 1 | 2010 | 1650 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 1998 | 5095 | 0.070 |
Why?
|
| Public Opinion | 1 | 2009 | 477 | 0.070 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 24913 | 0.070 |
Why?
|
| Radiotherapy | 1 | 2012 | 1525 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1420 | 0.070 |
Why?
|
| Ventilators, Mechanical | 1 | 2007 | 292 | 0.070 |
Why?
|
| Age Distribution | 1 | 2011 | 2900 | 0.070 |
Why?
|
| Retinitis Pigmentosa | 1 | 1989 | 386 | 0.070 |
Why?
|
| Retroperitoneal Space | 2 | 2018 | 172 | 0.060 |
Why?
|
| False Negative Reactions | 2 | 2018 | 587 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 425 | 0.060 |
Why?
|
| Urine | 1 | 2006 | 370 | 0.060 |
Why?
|
| Workload | 1 | 2011 | 849 | 0.060 |
Why?
|
| Afghanistan | 1 | 2004 | 81 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 793 | 0.060 |
Why?
|
| Iraq | 1 | 2004 | 92 | 0.060 |
Why?
|
| Canada | 1 | 2010 | 2061 | 0.060 |
Why?
|
| Needles | 1 | 2008 | 448 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2017 | 40450 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 514 | 0.060 |
Why?
|
| Income | 2 | 2011 | 1904 | 0.060 |
Why?
|
| Models, Economic | 1 | 2009 | 713 | 0.060 |
Why?
|
| Blood Pressure | 3 | 2010 | 8541 | 0.060 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2005 | 93 | 0.060 |
Why?
|
| Economics, Hospital | 1 | 2007 | 213 | 0.060 |
Why?
|
| Self Care | 2 | 2000 | 786 | 0.060 |
Why?
|
| Space Perception | 1 | 1988 | 474 | 0.060 |
Why?
|
| Medicare Part D | 1 | 2009 | 326 | 0.060 |
Why?
|
| Trauma Centers | 1 | 2009 | 889 | 0.060 |
Why?
|
| Leg | 1 | 2009 | 1110 | 0.060 |
Why?
|
| Device Removal | 1 | 2009 | 652 | 0.060 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2017 | 1457 | 0.060 |
Why?
|
| Hydrothorax | 1 | 2003 | 16 | 0.060 |
Why?
|
| Survival Rate | 3 | 2015 | 12773 | 0.060 |
Why?
|
| Hospitals, Teaching | 2 | 2013 | 1179 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 1760 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2502 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2714 | 0.060 |
Why?
|
| Anaphylaxis | 1 | 2011 | 746 | 0.060 |
Why?
|
| Medicaid | 2 | 2017 | 2716 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2012 | 1368 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 670 | 0.060 |
Why?
|
| Radiopharmaceuticals | 3 | 2013 | 2658 | 0.060 |
Why?
|
| Cystectomy | 1 | 2009 | 682 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 469 | 0.060 |
Why?
|
| Vancomycin Resistance | 1 | 2004 | 128 | 0.060 |
Why?
|
| Lasers | 1 | 1988 | 952 | 0.060 |
Why?
|
| ROC Curve | 1 | 2011 | 3528 | 0.060 |
Why?
|
| Hernia, Inguinal | 1 | 2005 | 202 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2004 | 198 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2012 | 1197 | 0.060 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 2906 | 0.060 |
Why?
|
| Survivors | 1 | 2013 | 2286 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 840 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2020 | 1839 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 2006 | 592 | 0.050 |
Why?
|
| Preoperative Period | 2 | 2018 | 546 | 0.050 |
Why?
|
| Light | 1 | 1989 | 1374 | 0.050 |
Why?
|
| Attitude to Computers | 1 | 2003 | 202 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 2 | 2012 | 44 | 0.050 |
Why?
|
| Reference Values | 1 | 2009 | 4982 | 0.050 |
Why?
|
| Hypotension | 1 | 2008 | 880 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20086 | 0.050 |
Why?
|
| Medicine | 1 | 2010 | 941 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1617 | 0.050 |
Why?
|
| Education, Medical | 1 | 2014 | 1717 | 0.050 |
Why?
|
| Calcium | 4 | 2022 | 5753 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 651 | 0.050 |
Why?
|
| Eye Injuries | 1 | 2004 | 245 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2012 | 2145 | 0.050 |
Why?
|
| Computers, Handheld | 1 | 2003 | 208 | 0.050 |
Why?
|
| Death | 1 | 2006 | 675 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 2267 | 0.050 |
Why?
|
| Sex Offenses | 1 | 2005 | 352 | 0.050 |
Why?
|
| Blast Injuries | 1 | 2004 | 302 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 1581 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6191 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 1431 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 11001 | 0.050 |
Why?
|
| Documentation | 1 | 2007 | 865 | 0.050 |
Why?
|
| Health Personnel | 2 | 2016 | 3210 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4229 | 0.050 |
Why?
|
| MEDLARS | 1 | 2000 | 5 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2007 | 760 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 1461 | 0.040 |
Why?
|
| Utah | 1 | 1999 | 126 | 0.040 |
Why?
|
| Colorado | 1 | 1999 | 162 | 0.040 |
Why?
|
| Information Services | 1 | 2000 | 244 | 0.040 |
Why?
|
| Scotland | 1 | 2019 | 155 | 0.040 |
Why?
|
| Peer Review, Health Care | 1 | 2019 | 75 | 0.040 |
Why?
|
| Judgment | 1 | 2001 | 281 | 0.040 |
Why?
|
| Intuition | 1 | 1998 | 20 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1849 | 0.040 |
Why?
|
| Visual Acuity | 1 | 1988 | 2520 | 0.040 |
Why?
|
| Thailand | 1 | 2019 | 296 | 0.040 |
Why?
|
| Angiostatins | 1 | 1998 | 67 | 0.040 |
Why?
|
| Ghana | 1 | 2019 | 287 | 0.040 |
Why?
|
| Primary Nursing | 1 | 2017 | 11 | 0.040 |
Why?
|
| Endostatins | 1 | 1998 | 174 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2008 | 4197 | 0.040 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 1668 | 0.040 |
Why?
|
| Fee-for-Service Plans | 2 | 2013 | 694 | 0.040 |
Why?
|
| Algorithms | 2 | 2014 | 13853 | 0.040 |
Why?
|
| Medication Errors | 1 | 2003 | 797 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 1204 | 0.040 |
Why?
|
| Retina | 1 | 1988 | 2611 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2018 | 235 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2021 | 692 | 0.040 |
Why?
|
| Prognosis | 5 | 2018 | 29010 | 0.040 |
Why?
|
| Radiography | 1 | 2008 | 7010 | 0.040 |
Why?
|
| Family Planning Services | 1 | 2019 | 258 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 425 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2016 | 63 | 0.030 |
Why?
|
| Confidentiality | 1 | 2000 | 609 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2017 | 299 | 0.030 |
Why?
|
| Oceania | 1 | 2015 | 17 | 0.030 |
Why?
|
| Spouses | 1 | 2018 | 284 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2229 | 0.030 |
Why?
|
| Cuba | 1 | 2015 | 47 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2018 | 390 | 0.030 |
Why?
|
| Sepsis | 1 | 2010 | 2589 | 0.030 |
Why?
|
| Groin | 1 | 2016 | 102 | 0.030 |
Why?
|
| Military Personnel | 1 | 2004 | 1132 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 1449 | 0.030 |
Why?
|
| Americas | 1 | 2015 | 111 | 0.030 |
Why?
|
| Health Benefit Plans, Employee | 1 | 1998 | 332 | 0.030 |
Why?
|
| Moldova | 1 | 2015 | 15 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 878 | 0.030 |
Why?
|
| Public Sector | 1 | 2017 | 264 | 0.030 |
Why?
|
| Curriculum | 2 | 2022 | 3589 | 0.030 |
Why?
|
| Governing Board | 1 | 2015 | 53 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13655 | 0.030 |
Why?
|
| Oxygen | 1 | 2006 | 4169 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 275 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 237 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6754 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2000 | 725 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2022 | 12695 | 0.030 |
Why?
|
| Geography | 1 | 2016 | 669 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 440 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2016 | 256 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 562 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 867 | 0.030 |
Why?
|
| Anthropometry | 1 | 2018 | 1350 | 0.030 |
Why?
|
| Technetium | 1 | 2013 | 334 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 591 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2018 | 659 | 0.030 |
Why?
|
| Schools | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Acute Disease | 2 | 2013 | 7141 | 0.030 |
Why?
|
| France | 1 | 2013 | 517 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2012 | 174 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 508 | 0.030 |
Why?
|
| Live Birth | 1 | 2015 | 512 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35342 | 0.030 |
Why?
|
| Counseling | 1 | 2019 | 1521 | 0.020 |
Why?
|
| Laparoscopy | 2 | 2018 | 2121 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 846 | 0.020 |
Why?
|
| Carcinoma, Medullary | 1 | 2011 | 123 | 0.020 |
Why?
|
| Ownership | 1 | 2013 | 331 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 458 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1771 | 0.020 |
Why?
|
| Cell Division | 1 | 1998 | 4564 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 939 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2017 | 1093 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2011 | 347 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 200 | 0.020 |
Why?
|
| ras Proteins | 1 | 2015 | 1060 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 12958 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 2275 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2924 | 0.020 |
Why?
|
| China | 1 | 2015 | 2246 | 0.020 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2011 | 143 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 2013 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2011 | 241 | 0.020 |
Why?
|
| Perception | 1 | 2016 | 1188 | 0.020 |
Why?
|
| Adaptation, Ocular | 1 | 1989 | 93 | 0.020 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 1288 | 0.020 |
Why?
|
| Phenotype | 2 | 2017 | 16331 | 0.020 |
Why?
|
| Goals | 1 | 2014 | 705 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3339 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 13921 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 438 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 2011 | 405 | 0.020 |
Why?
|
| Motivation | 1 | 2018 | 1968 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 1679 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 1989 | 219 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1998 | 2633 | 0.020 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2011 | 325 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2885 | 0.020 |
Why?
|
| Contrast Sensitivity | 1 | 1989 | 244 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2019 | 2235 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 1989 | 394 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1988 | 176 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 3490 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19862 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2011 | 749 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4187 | 0.020 |
Why?
|
| Lawyers | 1 | 2006 | 38 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2948 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 1507 | 0.020 |
Why?
|
| Training Support | 1 | 2006 | 113 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2533 | 0.020 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2005 | 92 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1107 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4839 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21719 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4801 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2458 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3584 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2010 | 2290 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 1988 | 936 | 0.010 |
Why?
|
| Exercise | 1 | 2020 | 5611 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3585 | 0.010 |
Why?
|
| Age Factors | 2 | 2013 | 18355 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4553 | 0.010 |
Why?
|
| Poverty | 1 | 2014 | 2646 | 0.010 |
Why?
|
| Telemedicine | 1 | 2000 | 2853 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2043 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 1986 | 482 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10372 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6259 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 1254 | 0.010 |
Why?
|
| Pneumonia | 1 | 2013 | 2117 | 0.010 |
Why?
|
| Rabbits | 1 | 1988 | 4886 | 0.010 |
Why?
|
| Mutation | 2 | 2016 | 29717 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 1679 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15194 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1986 | 1071 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10392 | 0.010 |
Why?
|
| Mass Screening | 1 | 2014 | 5238 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7873 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 20774 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10472 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 8333 | 0.010 |
Why?
|
| Animals | 3 | 1998 | 168561 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 8455 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11690 | 0.010 |
Why?
|
| Mice | 1 | 1998 | 81045 | 0.010 |
Why?
|
| Heart Failure | 1 | 2013 | 10856 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1986 | 962 | 0.000 |
Why?
|
| Lens, Crystalline | 1 | 1986 | 388 | 0.000 |
Why?
|
| Cattle | 1 | 1986 | 3923 | 0.000 |
Why?
|